Opus Genetics, Inc.
IRD
$4.90
-$0.30-5.68%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.52M | -17.45M | -7.42M | -8.19M | -35.14M |
| Total Depreciation and Amortization | 13.00K | 13.00K | 14.00K | 13.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.60M | 10.41M | -55.00K | -519.00K | 26.28M |
| Change in Net Operating Assets | 73.00K | 875.00K | -2.81M | -294.00K | 1.41M |
| Cash from Operations | -9.83M | -6.16M | -10.27M | -8.99M | -7.44M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 1.21M |
| Cash from Investing | -- | -- | -- | -- | 1.21M |
| Total Debt Issued | 0.00 | 0.00 | 1.00M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 24.32M | 5.24M | 0.00 | 6.39M | 0.00 |
| Repurchase of Common Stock | -116.00K | 0.00 | 0.00 | -36.00K | -37.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -98.00K | -696.00K | -94.00K | 14.11M | -46.00K |
| Cash from Financing | 24.11M | 4.54M | 906.00K | 20.47M | -83.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.28M | -1.61M | -9.36M | 11.47M | -6.31M |